VERSANT VOYAGEURS III (CANADA), L.P.
Profile
Company Names
VERSANT VOYAGEURS III (CANADA), L.P.
Addresses
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO, CA 94104
Phone Numbers
415-801-8100
Entity Type:
LIMITED PARTNERSHIP
Industry:
VENTURE CAPITAL FUND
Year Incorporated:
2022
State Incorporated:
ONTARIO, CANADA
Total Amount Raised:
$300,178,571.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-10-12
$300,178,571.00
$300,178,571.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRADLEY
BOLZON
EXECUTIVE OFFICER
METABOLEX, INC.
| FLEXION THERAPEUTICS INC
| INCEPTION 3, INC.
| INCEPTION 4, INC.
| VERSANT VENTURE CAPITAL V, L.P.
| VERSANT AFFILIATES FUND V, L.P.
| VERSANT OPHTHALMIC AFFILIATES I, L.P.
| VERSANT VENTURE CAPITAL V (CANADA), LP
| INCEPTION 5, INC.
| INCEPTION IBD, INC.
| CRISPR THERAPEUTICS AG
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| BLACK DIAMOND THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VII, L.P.
| NORTHERN MOSAIC LP
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| MONTE ROSA THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
JEREL
DAVIS
EXECUTIVE OFFICER
CHANRX CORP.
| LAGUNA PHARMACEUTICALS, INC.
| INCEPTION IBD, INC.
| TRAVUS THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VI, L.P.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| VERSANT VENTURE CAPITAL VII, L.P.
| TURNSTONE BIOLOGICS CORP.
| NORTHERN MOSAIC LP
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| CHINOOK THERAPEUTICS U.S., INC.
| VENTUS THERAPEUTICS U.S., INC.
| TENTARIX BIOTHERAPEUTICS, LP
| RAYZEBIO, INC.
| GRAPHITE BIO, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| SANTA ANA BIO, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| FIREFLY BIO, INC.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
ALEX
MAYWEG
EXECUTIVE OFFICER
VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
CLARE
OZAWA
EXECUTIVE OFFICER
INCEPTION IBD, INC.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VII, L.P.
| OYSTER POINT PHARMA, INC.
| 858 THERAPEUTICS, INC.
| LYCIA THERAPEUTICS, INC.
| JENGU THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| MARCH THERAPEUTICS, INC.
| LENZ THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
CARLO
RIZZUTO
EXECUTIVE OFFICER
VENATORX PHARMACEUTICALS, INC.
| QUENTIS THERAPEUTICS, INC.
| PANDION THERAPEUTICS, INC.
| PANDION THERAPEUTICS HOLDCO LLC
| GRAPHITE BIO, INC.
| CENTURY THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| JNANA THERAPEUTICS INC.
| NEXO THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| PEP2TANGO THERAPEUTICS, INC.
N/A
VERSANT VOYAGEURS III GP (CANADA), LLC
EXECUTIVE OFFICER
N/A
VERSANT VOYAGEURS III GP, L.P.
EXECUTIVE OFFICER
N/A
VERSANT VOYAGEURS III GP-GP, LLC
EXECUTIVE OFFICER
THOMAS
WOIWODE
EXECUTIVE OFFICER
EURO VENTURES 4, INC.
| AUDENTES THERAPEUTICS, INC.
| KANYOS BIO, INC.
| INCEPTION IBD, INC.
| CRISPR THERAPEUTICS AG
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| TEMPEST THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| VERSANT VENTURE CAPITAL VII, L.P.
| VIVIDION THERAPEUTICS, INC.
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| LYCIA THERAPEUTICS, INC.
| JENGU THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| SANTA ANA BIO, INC.
| TEMPEST THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
